CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer

European Journal of Epidemiology

Volumn 25, Issue 7, 2010, Pages 491-500

  Pavanello, Sofia ^a   Mastrangelo, Giuseppe ^a   Placidi, Donatella ^b   Campagna, Marcello ^b   Pulliero, Alessandra ^a   Carta, Angela ^b   Arici, Cecilia ^b   Porru, Stefano ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Bladder cancer; CYP1A2 genotype; Occupational environmental exposures

Indexed keywords

ADENINE; AROMATIC AMINE; CYTOCHROME P450 1A2; CYTOSINE; POLYCYCLIC AROMATIC HYDROCARBON; THYMINE; COFFEE; CYP1A2 PROTEIN, HUMAN;

ADULT; ARTICLE; BLADDER CANCER; CANCER RISK; CAUCASIAN; CIGARETTE SMOKING; COFFEE; CONTROLLED STUDY; DIET; DRINKING BEHAVIOR; ENVIRONMENTAL EXPOSURE; FOOD INTAKE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LEAFY VEGETABLE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; POPULATION RESEARCH; AGED; CASE CONTROL STUDY; GENETICS; ITALY; MIDDLE AGED; PREVALENCE; PROMOTER REGION; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; URINARY BLADDER NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COFFEE; CYTOCHROME P-450 CYP1A2; HUMANS; ITALY; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ODDS RATIO; POLYCYCLIC HYDROCARBONS, AROMATIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 77955560208     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-010-9479-8     Document Type: Article

References (60)

1. Landi MT, Sinha R, Lang NP, Kadlubar FF. Chapter 16. Human cytochrome P4501A2. In: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Moffetta P, editors. Metabolic polymorphisms and susceptibility to cancer. Lyon: IARC Scientific Publications, IARC; 1999. 148, p. 173-195.
2. H Bartsch U Nair A Risch M Rojas H Wikman K Alexandrov 2000 Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers Cancer Epidemiol Biomarkers Prev 9 3 28 1:CAS:528:DC%2BD3cXptVOmtw%3D%3D 10667460
3. MA Butler NP Lang JF Young NE Caporaso P Vineis RB Hayes CH Teitel JP Massengill MF Lawsen FF Kadlubar 1992 Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites Pharmacogenetics 2 116 127 10.1097/00008571-199206000-00003 1:CAS:528: DyaK3sXlsFWlsr0%3D 1306111
4. S Pavanello P Simioli S Lupi P Gregorio E Clonfero 2002 Exposure levels and cytochrome P450 1A2 activity, but not N-acetyltransferase, glutathione S-transferase (GST) M1 and T1, influence urinary mutagen excretion in smokers Cancer Epidemiol Biomarkers Prev 11 998 1003 1:CAS:528:DC%2BD38Xos1ektbc%3D 12376499
5. D Sesardic AR Boobis RJ Edwards DS Davies 1988 A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the odeethylation of phenacetin and is inducible by cigarette smoking Br J Clin Pharmacol 26 363 372 1:CAS:528:DyaL1MXhvFOgsw%3D%3D 3190986
6. WG Chung JH Kang CS Park MH Cho YN Cha 2000 Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism Clin Pharmacol Ther 67 258 266 10.1067/mcp.2000.104617 1:CAS:528:DC%2BD3cXis1Ghtr0%3D 10741629
7. A Nordmark S Lundgren S Cnattingius A Rane 1999 Dietary caffeine as a probe agent for assessment of cytochrome P4501A2 activity in random urine samples Br J Clin Pharmacol 47 397 402 10.1046/j.1365-2125.1999.00918.x 1:CAS:528:DyaK1MXivVCmt7k%3D 10233204 (Pubitemid 29161272)
8. S Pavanello A Pulliero S Lupi P Gregorio E Clonfero 2005 Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers Mutat Res 587 59 66 1:CAS:528:DC%2BD2MXhtFKms7%2FE 16188490
9. S Pavanello F B'chir A Pulliero S Saguem R Ben Fraj A El Aziz Hayouni E Clonfero G Mastrangelo 2007 Interaction between CYP1A2-T2467DELT polymorphism and smoking in adenocarcinoma and squamous cell carcinoma of the lung Lung Cancer 57 266 272 10.1016/j.lungcan.2007.04.004 17509724 (Pubitemid 47285430)
10. International Agency for Research on Cancer. World cancer report 2008. In: Boyle P, Levin B, editors. WHO Press, Geneva; 2008.
11. AIRT Working Group. Italian cancer figures-report 2006: 1. Incidence, mortality and estimates. Epidemiol Prev 2006; 30: 8-101.
12. C Pelucchi C Bosetti E Negri M Malvezzi C La Vecchia 2006 Mechanisms of disease: the epidemiology of bladder cancer Nat Clin Pract Urol 3 327 340 10.1038/ncpuro0510 1:CAS:528:DC%2BD28XmtlWntbo%3D 16763645 (Pubitemid 43871794)
13. Kogevinas M, Trichopoulos D. Urinary bladder cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. New York: Oxford University Press; 2002. p. 446-66.
14. ALJ Kamat J Gu M Chen CP Dinney MR Forman X Wu 2009 Dietary intake of vegetables and fruit and the modification effects of GSTM1 and NAT2 genotypes on bladder cancer risk Cancer Epidemiol Biomarkers Prev 18 2090 2097 10.1158/1055-9965.EPI-08-1174 19549811
15. E Kellen M Zeegers A Paulussen M Van Dongen F Buntinx 2006 Fruit consumption reduces the effect of smoking on bladder cancer risk. The Belgian case control study on bladder cancer Int J Cancer 118 2572 2578 10.1002/ijc.21714 1:CAS:528:DC%2BD28XktlGhsr0%3D 16380991
16. R García-Closas M García-Closas M Kogevinas N Malats D Silverman C Serra A Tardón A Carrato G Castaño-Vinyals M Dosemeci L Moore N Rothman, et al. 2007 Food, nutrient and heterocyclic amine intake and the risk of bladder cancer Eur J Cancer 43 1731 1740 10.1016/j.ejca.2007.05.007 17596928 (Pubitemid 47053885)
17. E Riboli T Norat 2003 Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk Am J Clin Nutr 78 559 569
18. FL Büchner HB Bueno-de-Mesquita MM Ros E Kampman L Egevad K Overvad O Raaschou-Nielsn A Tiønneland N Roswall F Clavel-Chapelon MC Boutron-Ruault M Touillaud J Chang-Claude R Kaaks H Boeing S Weikert A Trichopoulou P Lagiou D Trichopoulos D Palli S Sieri P Vineis R Tumino S Panico A Vrieling PH Peeters CH van Gils E Luund IT Gram D Engeset C Martinez CA Gonzalez N Larrañaga E Ardanaz C Navarro L Rodriguez J Manjer RA Ehrnström G Hallmans B Ljungberg NE Allen AVV Roddam S Bingham KT Khaw N Silmani P Boffetta M Jenab T Mouw DS Michaud LA Kiemeney E Riboli 2009 Consumption of vegetables and fruit and the risk of bladder cancer in the European prospective investigation into cancer and nutrition Int J Cancer 125 2643 2651 10.1002/ijc.24582 19618458
19. SC Larsson SO Andersson JE Johansson A Wolk 2008 Fruit and vegetable consumption and risk of bladder cancer: a prospective cohort study Cancer Epidemiol Biomarkers Prev 17 2519 2522 10.1158/1055-9965.EPI-08-0407 18768526
20. International Agency for Research on Cancer (IARC). Coffee, tea, mate, methylxanthines and methylglyoxal. In: IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon; 1991.
21. L Covolo D Placidi U Gelatti A Carta A Scotto Di Carlo P Lodetti A Piccichè G Orizio M Campagna C Arici S Porru 2008 Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study Eur J Epidemiol 23 355 362 10.1007/s10654-008-9238-2 1:CAS:528:DC%2BD1cXkvFyltLo%3D 18365755
22. M Sala S Cordier J Chang-Claude F Donato A Escolar-Pujolar F Fernandez CA González E Greiser KH Jöckel E Lynge A Mannetje H Pohlabeln, et al. 2000 Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries Cancer Causes Control 11 925 931 10.1023/A:1026524014954 1:STN:280:DC%2BD3M7jvVSisg%3D%3D 11142527 (Pubitemid 32005304)
23. C Pelucchi C La Vecchia 2009 Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies Eur J Cancer Prev 18 62 68 10.1097/CEJ.0b013e32830c8d44 19077567
24. CM Villanueva DT Silverman C Murta-Nascimento N Malats M Garcia-Closas F Castro A Tardon R Garcia-Closas C Serra A Carrato N Rothman FX Real, et al. 2009 Coffee consumption, genetic susceptibility and bladder cancer risk Cancer Causes Control 20 121 127 10.1007/s10552-008-9226-6 18798002
25. CG Woolcott WD King LD Marrett 2002 Coffee and tea consumption and cancers of the bladder, colon and rectum Eur J Cancer Prev 11 137 145 10.1097/00008469-200204000-00005 1:STN:280:DC%2BD383msFOitw%3D%3D 11984131 (Pubitemid 34478430)
26. MP Zeegers FE Tan RA Goldbohm PA van den Brandt 2001 Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis Int J Epidemiol 30 353 362 10.1093/ije/30.2.353 1:STN:280:DC%2BD3M3nsFWksw%3D%3D 11369742
27. RJ Hung P Boffetta P Brennan C Malaveille A Hautefeuille F Donato U Gelatti M Spaliviero D Placidi A Carta A Scotto di Carlo S Porru 2004 GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population Int J Cancer 110 598 604 10.1002/ijc.20157 1:CAS:528:DC%2BD2cXktlKkur4%3D 15122594 (Pubitemid 38658026)
28. M Shen RJ Hung P Brennan C Malaveille F Donato D Placidi A Carta A Hautefeuille P Boffetta S Porru 2003 Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy Cancer Epidemiol Biomarkers Prev 12 1234 1240 1:CAS:528:DC%2BD3sXptlyjtb0%3D 14652287
29. RJ Hung P Boffetta P Brennan C Malaveille U Gelatti D Placidi A Carta A Hautefeuille S Porru 2004 Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk Carcinogenesis 25 973 978 10.1093/carcin/bgh080 1:CAS:528:DC%2BD2cXksVahtrk%3D 14729580 (Pubitemid 38886083)
30. Schlesselman JJ. Case-control studies: design, conduct, analysis. USA: Oxford University Press; 1982. p. 145.
31. Cohen J, Cohen P, West SG, Aiken LS. Applied multiple regression/correlation analysis for the behavioral sciences. 3rd ed. Mahwah, NJ: Lawrence Earlbaum Associates; 2003.
32. Q Yang MJ Khoury WD Flanders 1997 Sample size requirements in case-only designs to detect gene-environment interaction Am J Epidemiol 146 713 720 1:STN:280:DyaK1c%2FjtlCisQ%3D%3D 9366618
33. S Porru D Placidi A Carta U Gelatti ML Ribero A Tagger P Boffetta F Donato 2001 Primary liver cancer and occupation in men: a case-control study in high-incidence area in Northern Italy Int J Cancer 94 878 883 10.1002/ijc.1538 1:CAS:528:DC%2BD3MXotFOku7g%3D 11745492 (Pubitemid 33034613)
34. E Altayli S Gunes AF Yilmaz S Goktas Y Bek 2009 CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population Int Urol Nephrol 41 259 266 10.1007/s11255-008-9444-6 1:CAS:528:DC%2BD1MXlsFKrsL8%3D 18690546
35. JD Figueroa N Malats M García-Closas FX Real D Silverman M Kogevinas S Chanock R Welch M Dosemeci Q Lan A Tardón C Serra, et al. 2008 Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes Carcinogenesis 29 1955 1962 10.1093/carcin/bgn163 1:CAS:528: DC%2BD1cXht1SitLvO 18632753
36. LC Quattrochi T Vu RH Tukey 1994 The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction J Biol Chem 269 6949 6954 1:CAS:528: DyaK2cXivFWhurc%3D 8120057
37. K Sogawa Y Fujii-Kuriyama 1997 Ah receptor, a novel ligand-activated transcription factor J Biochem 122 1075 1079 1:CAS:528:DyaK1cXmtFegsA%3D%3D 9498548
38. O Hankinson 1995 The aryl hydrocarbon receptor complex Annu Rev Pharmacol Toxicol 35 307 340 10.1146/annurev.pa.35.040195.001515 1:CAS:528: DyaK2MXlt1Grurc%3D 7598497
39. S Hayashi J Watanabe K Kawajiri 1991 Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene J Biochem 110 559 565 1:CAS:528:DyaK3MXmslaitLY%3D 1778977
40. International Agency for Research on Cancer (IARC). Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. In: Lyon: IARC Scientific Publications; 2004; 83: 1-1438.
41. H Bartsch N Caporaso M Coda F Kadlubar C Malaveille P Skipper G Talaska SR Tannenbaum P Vineis 1990 Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers J Natl Cancer Inst 82 1826 1831 10.1093/jnci/82.23.1826 1:STN:280:DyaK3M%2Fms1ensw%3D%3D 2250298
42. P Vineis G Talaska C Malaveille H Bartsch T Martone P Sithisarankul P Strickland 1996 DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke Int J Cancer 65 314 316 10.1002/(SICI)1097-0215(19960126)65:3<314::AID- IJC6>3.0.CO;2-2 1:CAS:528:DyaK28Xhs1Shs70%3D 8575850 (Pubitemid 26059985)
43. SS Hecht 2006 Cigarette smoking: cancer risks, carcinogens, and mechanisms Langenbecks Arch Surg 391 603 613 10.1007/s00423-006-0111-z 17031696 (Pubitemid 44657742)
44. G Talaska AZSS Al-Juburi FF Kadlubar 1991 Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct Proc Natl Acad Sci USA 88 5350 5354 10.1073/pnas.88.12.5350 1:CAS:528:DyaK3MXks1Kltrc%3D 2052611
45. G Curigliano YJ Zhang LY Wang G Flamini A Alcini C Ratto M Giustacchini E Alcini A Cittadini RM Santella 1996 Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers Carcinogenesis 17 911 916 10.1093/carcin/17.5.911 1:CAS:528:DyaK28Xjt1Kltr0%3D 8640937 (Pubitemid 26158384)
46. Z Feng W Hu WN Rom FA Beland MS Tang 2002 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene Carcinogenesis 23 1721 1727 10.1093/carcin/23.10.1721 1:CAS:528:DC%2BD38XnvF2qtr0%3D 12376482
47. F Saletta G Matullo M Manuguerra S Arena A Bardelli P Vineis 2007 Exposure to the tobacco smoke constituent 4-Aminobiphenyl induces chromosomal instability in human cancer cells Cancer Res 67 7088 7094 10.1158/0008-5472.CAN- 06-4420 1:CAS:528:DC%2BD2sXosVemsLY%3D 17671175 (Pubitemid 47206535)
48. MA Butler FP Guengerich FF Kadlubar 1989 Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4, 4′-methylenebis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases Cancer Res 49 25 31 1:CAS:528:DyaL1MXhtV2rsL4%3D 2908851
49. FF Kadlubar JA Miller EC Miller 1977 Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis Cancer Res 37 805 814 1:CAS:528:DyaE2sXhs1KiurY%3D 13929
50. Kadlubar FF. Carcinogenic aromatic amine metabolism and DNA adduct detection in human. In: Emster L, editor. Xenobiotics and cancer. London: Taylor & Francis, Ltd.; 1991. p. 329-38.
51. H Bartsch C Malaveille M Friesen FF Kadlubar P Vineis 1993 Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV. Molecular dosimetrystudies implicates aromatic amines as bladder carcinogens Eur J Cancer 29 1199 1207 10.1016/S0959-8049(05)80315-6
52. SM Frederickson EM Messing CA Renikoff S Swaminathan 1994 Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells Cancer Epidemiol Biomark Prev 3 25 32 1:CAS:528:DyaK2cXivFWlsbw%3D
53. B Sinués MA Sáenz J Lanuza ML Bernal A Fanlo JL Juste E Mayayo 1999 Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow Cancer Epidemiol Biomarkers Prev 8 159 166 10067814
54. S Murray BG Lake S Gray AJ Edwards C Springall EA Bowey G Williamson AR Boobis NJ Gooderham 2001 Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man Carcinogenesis 22 1413 1420 10.1093/carcin/22.9.1413 1:CAS:528:DC%2BD3MXmvVymtLs%3D 11532863
55. S Pavanello P Simioli G Mastrangelo S Lupi G Gabbani P Gregorio E Clonfero 2002 Role of metabolic polymorphisms NAT2 and CYP1A2 on urinary mutagenicity after a pan-fried hamburger meal Food Chem Toxicol 40 1139 1144 10.1016/S0278-6915(02)00038-8 1:CAS:528:DC%2BD38XksVamtbY%3D 12067576 (Pubitemid 34626879)
56. MT Landi C Zocchetti I Bernucci FF Kadlubar S Tannenbaum P Skipper H Bartsch C Malaveille P Shields NE Caporaso P Vineis 1996 Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels Cancer Epidemiol Biomarkers Prev 5 693 698 1:CAS:528: DyaK28XmtF2ksr4%3D 8877060
57. FF Kadlubar KL Dooley CH Teitel DW Roberts RW Benson MA Butler JR Bailey JF Young PW Skipper SR Tannenbaum 1991 The frequency of urination and its effects on metabolism pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in Beagle dogs administered the carcinogen, 4-aminobiphenyl Cancer Res 51 4371 4377 1:CAS:528:DyaK3MXmtVSrtro%3D 1868460
58. M Chen AM Kamat M Huang HB Grossman CP Dinney SP Lerner X Wu J Gu 2007 High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk Carcinogenesis 28 2160 2165 10.1093/carcin/bgm167 1:CAS:528:DC%2BD2sXhtFeqs7nE 17728339 (Pubitemid 47543377)
59. M Manuguerra G Matullo F Veglia H Autrup AM Dunning S Garte E Gormally C Malaveille S Guarrera S Polidoro F Saletta M Peluso, et al. 2007 Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions Carcinogenesis 28 414 422 10.1093/carcin/bgl159 1:CAS:528:DC%2BD2sXhs1Srs78%3D 16956909 (Pubitemid 46321858)
60. AS Andrew HH Nelson KT Kelsey JH Moore AC Meng DP Casella TD Tosteson AR Schned MR Karagas 2006 Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility Carcinogenesis 27 1030 1037 10.1093/carcin/bgi284 1:CAS:528:DC%2BD28XjslKrs74%3D 16311243